Perceptive Advisors LLC Amarin Corp Plcuk Transaction History

Perceptive Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $28.4 Million - $153 Million	-7,106,079 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $7.39 Million - $12.8 Million	-530,000 Reduced 6.94%	7,106,079 $152 Million
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $19.9 Million - $33.2 Million	1,434,810 Added 23.14%	7,636,079 $116 Million
Q2 2019 Aug 14, 2019	SELL	$16.27 - $20.51 $5.53 Million - $6.97 Million	-339,688 Reduced 5.19%	6,201,269 $120 Million
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $21 Million - $37.2 Million	1,665,357 Added 34.16%	6,540,957 $136 Million
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $52.9 Million - $98 Million	4,265,400 Added 699.02%	4,875,600 $64.6 Million
Q3 2018 Nov 14, 2018	BUY	$2.45 - $16.27 $1.49 Million - $9.93 Million	610,200 New	610,200 $9.93 Million

183

71.2M

183K

66.7K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $185M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.